HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 196 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $1,765,000 | +74.2% | 98,120 | +71.8% | 0.18% | +206.9% |
Q4 2019 | $1,013,000 | +107.2% | 57,125 | +81.3% | 0.06% | +152.2% |
Q3 2019 | $489,000 | -9.6% | 31,515 | 0.0% | 0.02% | -4.2% |
Q2 2019 | $541,000 | +6.7% | 31,515 | 0.0% | 0.02% | +20.0% |
Q1 2019 | $507,000 | -56.1% | 31,515 | -60.1% | 0.02% | -57.4% |
Q4 2018 | $1,156,000 | +0.7% | 78,990 | +25.0% | 0.05% | +38.2% |
Q3 2018 | $1,148,000 | -6.9% | 63,200 | -13.5% | 0.03% | -10.5% |
Q2 2018 | $1,233,000 | -73.2% | 73,105 | -68.9% | 0.04% | -74.1% |
Q1 2018 | $4,609,000 | -0.4% | 235,260 | +3.0% | 0.15% | +4.3% |
Q4 2017 | $4,628,000 | +30.9% | 228,440 | +12.2% | 0.14% | +25.9% |
Q3 2017 | $3,536,000 | -12.6% | 203,595 | -35.5% | 0.11% | +2.8% |
Q2 2017 | $4,044,000 | +83.5% | 315,440 | +85.5% | 0.11% | +73.0% |
Q1 2017 | $2,204,000 | +33.3% | 170,030 | +1.7% | 0.06% | +43.2% |
Q4 2016 | $1,653,000 | +62.7% | 167,260 | +98.9% | 0.04% | +57.1% |
Q3 2016 | $1,016,000 | +535.0% | 84,090 | +566.1% | 0.03% | +600.0% |
Q1 2014 | $160,000 | -18.8% | 12,625 | -4.0% | 0.00% | -33.3% |
Q4 2013 | $197,000 | – | 13,150 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |